- Home
- SNY vs MMC Comparison
SNY vs MMC Comparison
Compare SNY & MMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- MMC
- Stock Information
- Founded
- SNY 1994
- MMC 1871
- Country
- SNY France
- MMC United States
- Employees
- SNY N/A
- MMC N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- MMC Specialty Insurers
- Sector
- SNY Health Care
- MMC Finance
- Exchange
- SNY Nasdaq
- MMC Nasdaq
- Market Cap
- SNY 116.1B
- MMC 103.4B
- IPO Year
- SNY N/A
- MMC N/A
- Fundamental
- Price
- SNY $52.02
- MMC $182.67
- Analyst Decision
- SNY Buy
- MMC Hold
- Analyst Count
- SNY 4
- MMC 15
- Target Price
- SNY $61.50
- MMC $222.93
- AVG Volume (30 Days)
- SNY 2.3M
- MMC 3.0M
- Earning Date
- SNY 10-24-2025
- MMC 10-16-2025
- Dividend Yield
- SNY 3.07%
- MMC 1.97%
- EPS Growth
- SNY 105.93
- MMC 2.86
- EPS
- SNY 8.67
- MMC 8.34
- Revenue
- SNY $53,890,648,839.00
- MMC $26,453,000,000.00
- Revenue This Year
- SNY $2.37
- MMC $11.28
- Revenue Next Year
- SNY $6.51
- MMC $5.04
- P/E Ratio
- SNY $11.84
- MMC $21.92
- Revenue Growth
- SNY N/A
- MMC 10.47
- 52 Week Low
- SNY $44.62
- MMC $174.18
- 52 Week High
- SNY $60.12
- MMC $248.00
- Technical
- Relative Strength Index (RSI)
- SNY 63.33
- MMC 43.08
- Support Level
- SNY $48.55
- MMC $181.23
- Resistance Level
- SNY $52.68
- MMC $185.33
- Average True Range (ATR)
- SNY 0.68
- MMC 3.25
- MACD
- SNY 0.15
- MMC 1.05
- Stochastic Oscillator
- SNY 85.01
- MMC 75.35
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About MMC Marsh & McLennan Companies Inc.
Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.